{"database": "lobbying", "table": "lobbying_activities", "rows": [[2378181, "a503a74e-2d9b-4adb-afb2-2ec515a175ca", "Q4", "AMERICAN CAPITOL GROUP", 305852, "IPSEN BIOPHARMACEUTICALS, INC.", 2019, "fourth_quarter", "MMM", "Medicare Part D issues", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2020-01-07T14:50:06.493000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2378181"], "units": {}, "query_ms": 0.7979919901117682, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}